SygNola

SygNola is a full-service Clinical Research Organization (CRO) dedicated to advancing research in the field of wound medicine. Founded by a team of specialists with extensive clinical experience, the company provides comprehensive trial management, patient recruitment, and regulatory support for innovative wound healing technologies. SygNola focuses on complex wound challenges, including chronic diabetic ulcers, venous leg ulcers, and pressure injuries, utilizing advanced modalities such as cellular and matrix-like products (CAMPs) and regenerative therapies. By bridging the gap between clinical practice and research, SygNola aims to accelerate the development of breakthrough solutions that improve patient outcomes and reduce the economic burden of chronic wounds. The company operates primarily from its headquarters in Louisiana and partners with leading medical device and biotech sponsors to drive impactful clinical outcomes.